Theorizing an enhancement of the protection and of the justiciability of biorights in the European Union
The attention given to bioethics and biolaw has grown throughout the decades in the framework of the European Union, since the first steps were taken in the field of medical products, with the adoption of Council Directive 65/65/EEC. Moving from the EU Treaties, which provide the legal bases for bio...
| Autor: | |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2021 |
| País: | España |
| Institución: | Universidad de Sevilla (US) |
| Repositorio: | idUS. Depósito de Investigación de la Universidad de Sevilla |
| OAI Identifier: | oai:idus.us.es:11441/134147 |
| Acceso en línea: | https://hdl.handle.net/11441/134147 https://doi.org/10.12795/IETSCIENTIA.2021.i01.13 |
| Access Level: | acceso abierto |
| Palabra clave: | Court of Justice of the European Union European Court of Human Rights Biorights Human embryo research Surrogacy Abortion Cross-fertilization Tribunal de Justicia de la Unión Europea Tribunal Europeo de Derechos Humanos Bioderechos Investigación con embriones humanos Maternidad subrogada Fertilización cruzada jurisprudencial |
| Sumario: | The attention given to bioethics and biolaw has grown throughout the decades in the framework of the European Union, since the first steps were taken in the field of medical products, with the adoption of Council Directive 65/65/EEC. Moving from the EU Treaties, which provide the legal bases for bioethics and biorights as well as for some potentially competing principles and interests, as the four freedoms, this study adopts a human rights-based approach to biolaw and assesses the jurisprudence of the Court of Justice of the European Union and the role of the Charter of Fundamental Rights of the European Union (CFR) from this viewpoint. Comparison is made with the jurisprudence of the European Court of Human Rights, for analysing viable paths of judicial dialogue and cross-fertilization as a response to the challenges posed by biolaw, in line with Article 52(3) of the CFR. |
|---|